Tuberculosis chemoprophylaxis for diabetics: Are the benefits of isoniazid worth the risk?

D. N. Rose, A. L. Silver, C. B. Schechter

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Tuberculosis chemoprophylaxis for diabetics: Are the benefits of isoniazid worth the risk?'. Together they form a unique fingerprint.

Medicine & Life Sciences